“Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients With Psoriasis Who Had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s431. Accessed July 3, 2025. https://skin.dermsquared.com/skin/article/view/3043.